SGX Regco grants SAM Holdings’ extension for FY 2024 results

The company filed the application on 16 August with SGX Regco.

The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing.

This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December.

They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM.

Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.

Follow the link for more news on

Singapore

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia